Bechtold et al. also observed reduced pituitary GH secretion in children with JIA, particularly in those receiving systemic GC treatment, while Grote et al. identified a relative resistance to IGF-1, especially in children subjected to long-course treatment with GC [74,75]. This evidence concerns the gene IGF1 and juvenile idiopathic arthritis.